Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

February 06, 2018

Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company

Track this case

Case Number:

1:18-cv-10242

Court:

Massachusetts

Nature of Suit:

Patent

Judge:

Allison D. Burroughs

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 27, 2018

    Lilly Migraine Med's Uncertain Future Kills Teva's Patent Suit

    A Massachusetts federal judge on Thursday cleared Eli Lilly and Co. from allegations that it infringed nine Teva Pharmaceuticals patents by preparing to launch a new migraine biologic, finding the suit is premature given that the U.S. Food and Drug Administration is still deciding whether to approve Lilly's drug.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login